Skip to content
10-K

Annual Report

IsoPlexis Corporation

0001615055-22-000016

← back to feed
Filed
Mar 30, 2022 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding FY 2021 · Mar 28, 2022 39.04M sh
Shares Diluted FY 2021 · Dec 31, 2020 2.09M sh
Capex FY 2021 · Dec 31, 2020 $1.44M
Operating Cash Flow FY 2021 · Dec 31, 2020 −$22.43M
Long Term Debt FY 2021 · Dec 31, 2020 $22.14M
Cash And Equivalents FY 2021 · Dec 31, 2020 $106.64M
Current Liabilities FY 2021 · Dec 31, 2020 $4.62M
Total Liabilities FY 2021 · Dec 31, 2020 $31.4M
Current Assets FY 2021 · Dec 31, 2020 $115.67M
Total Assets FY 2021 · Dec 31, 2020 $123.61M
Eps Diluted FY 2021 · Dec 31, 2020 −$14.06
Eps Basic FY 2021 · Dec 31, 2020 −$14.06
Sga Expense FY 2021 · Dec 31, 2020 $8.02M
Rd Expense FY 2021 · Dec 31, 2020 $11.16M
Operating Income FY 2021 · Dec 31, 2020 −$27.28M
Gross Profit FY 2021 · Dec 31, 2020 $5.41M
Revenue FY 2021 · Dec 31, 2020 $10.39M
Stockholders Equity FY 2021 · Dec 31, 2019 −$28.53M